HK1255631A1 - Pharmaceutical composition for preventing and treating sleep disorders - Google Patents

Pharmaceutical composition for preventing and treating sleep disorders

Info

Publication number
HK1255631A1
HK1255631A1 HK18114767.2A HK18114767A HK1255631A1 HK 1255631 A1 HK1255631 A1 HK 1255631A1 HK 18114767 A HK18114767 A HK 18114767A HK 1255631 A1 HK1255631 A1 HK 1255631A1
Authority
HK
Hong Kong
Prior art keywords
preventing
pharmaceutical composition
sleep disorders
treating sleep
treating
Prior art date
Application number
HK18114767.2A
Other languages
Chinese (zh)
Inventor
弗拉基米爾‧維克托羅維奇‧涅斯捷魯克
基里爾‧康斯坦丁諾維奇‧瑟羅夫
Original Assignee
瓦倫塔有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瓦倫塔有限責任公司 filed Critical 瓦倫塔有限責任公司
Publication of HK1255631A1 publication Critical patent/HK1255631A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK18114767.2A 2016-02-18 2018-11-19 Pharmaceutical composition for preventing and treating sleep disorders HK1255631A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2016105535A RU2620855C1 (en) 2016-02-18 2016-02-18 Pharmaceutical composition for sleep disorders prevention and treatment
PCT/RU2017/000077 WO2017142442A1 (en) 2016-02-18 2017-02-16 Pharmaceutical composition for preventing and treating sleep disorders

Publications (1)

Publication Number Publication Date
HK1255631A1 true HK1255631A1 (en) 2019-08-23

Family

ID=59032329

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114767.2A HK1255631A1 (en) 2016-02-18 2018-11-19 Pharmaceutical composition for preventing and treating sleep disorders

Country Status (9)

Country Link
KR (1) KR20180101539A (en)
CN (1) CN108697645A (en)
BR (1) BR112018016725A2 (en)
CL (1) CL2018002337A1 (en)
EA (1) EA201891647A1 (en)
HK (1) HK1255631A1 (en)
MX (1) MX2018009921A (en)
RU (1) RU2620855C1 (en)
WO (1) WO2017142442A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1696959A2 (en) * 2003-12-24 2006-09-06 Sepracor, Inc. Melatonin combination therapy for improving sleep quality
EP2717698A4 (en) * 2011-06-09 2015-01-07 Requis Pharmaceuticals Inc Antihistamines combined with dietary supplements for improved health
FR3000896B1 (en) * 2013-01-14 2016-08-26 Philippe Perovitch GALENIC FORM FOR ADMINISTRATION OF ACTIVE INGREDIENT (S) FOR ACCELERATED INDUCTION OF SLEEP AND / OR TREATMENT OF SLEEP DISORDERS
WO2014138162A1 (en) * 2013-03-05 2014-09-12 Requis Pharmaceuticals Inc. Preparations for the treatment of sleep-related respiratory disorders

Also Published As

Publication number Publication date
MX2018009921A (en) 2018-11-09
BR112018016725A2 (en) 2019-04-30
WO2017142442A1 (en) 2017-08-24
CL2018002337A1 (en) 2018-11-30
CN108697645A (en) 2018-10-23
EA201891647A1 (en) 2018-12-28
RU2620855C1 (en) 2017-05-30
KR20180101539A (en) 2018-09-12

Similar Documents

Publication Publication Date Title
IL256085B (en) A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment
ZA201907158B (en) Methods and compositions for treating sleep apnea
HRP20210518T1 (en) 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
IL269174A (en) Methods for treating complement-mediated diseases and disorders
HK1258696A1 (en) Novel compositions and methods for treating or preventing dermal disorders
ZA201901055B (en) Treatment and prevention of sleep disorders
PL3362449T3 (en) Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis
HK1252813A1 (en) Therapeutic compounds and compositions for treating social disorders and substance use disorders
HK1257935A1 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
EP3677265A4 (en) Composition for preventing or treating sleep disorders
HK1257587A1 (en) Medicine for preventing and treating liver fibrosis and use of the medicine
IL250114A0 (en) Methods and compositions for treating hiv-related disorders
EP3262065C0 (en) Methods and compositions for treating dystroglycanopathy disorders
IL280389A (en) A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment
PT3290051T (en) Pharmaceutical composition for treating and/or preventing cancer
PT3236961T (en) Pharmaceutical composition for preventing or treating cancer and method using thereof
GB201519644D0 (en) Therapy and pharmaceutical composition
PL3650024T3 (en) Pharmaceutical composition for nasal administration comprising rifampicins for treating dementia
EP3552632A4 (en) Medicinal composition for treating and preventing chronic disease
HK1255631A1 (en) Pharmaceutical composition for preventing and treating sleep disorders
AU2017902338A0 (en) Sleep Disorder Composition and Treatment Thereof
AU2015902659A0 (en) Therapeutic compounds and compositions for treating social disorders and substance use disorders